Jarosz-Chobot P - Search Results

1

Kamińska H, Wieczorek P, Skała-Zamorowska E, Deja G, Jarosz-Chobot P. Kamińska H, et al. Pediatr Endocrinol Diabetes Metab. 2016;22(1):21-25. doi: 10.18544/PEDM-22.01.0046. Pediatr Endocrinol Diabetes Metab. 2016. PMID: 28132069 Free article. Review. English.

2

[Lipid disturbances in type 1 diabetes mellitus--cardiovascular risk factor].

Pedras J, Jarosz-Chobot P, Minkina-Pedras M, Deja G. Pedras J, et al. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2005;11(2):97-101. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2005. PMID: 15996339 Review. Polish.

3

[Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].

Minkina-Pedras M, Jarosz-Chobot P, Małecka-Tendera E, Deja G. Minkina-Pedras M, et al. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2005;11(3):171-6. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2005. PMID: 16232370 Clinical Trial. Polish.

4

[Evaluation of selected risk factors of atherosclerosis in children with type 1 diabetes mellitus and hypercholesterolemia].

Muchacka-Bianga M, Deja G, Jarosz-Chobot P, Małecka-Tendera E, Kalina M, Grychtoł M. Muchacka-Bianga M, et al. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2006;12(1):25-30. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2006. PMID: 16704858 Polish.

5

Is the association between TNF-alpha-308 A allele and DMT1 independent of HLA-DRB1, DQB1 alleles?

Deja G, Jarosz-Chobot P, Polańska J, Siekiera U, Małecka-Tendera E. Deja G, et al. Mediators Inflamm. 2006;2006(4):19724. doi: 10.1155/MI/2006/19724. Mediators Inflamm. 2006. PMID: 17047287 Free PMC article.

6

[Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].

Otto-Buczkowska E, Jarosz-Chobot P, Deja G. Otto-Buczkowska E, et al. Przegl Lek. 2006;63(4):234-8. Przegl Lek. 2006. PMID: 17080748 Polish.

7

Treatment of type 1 diabetes mellitus revealed below 7 years of age in the Diabetes Center of Silesia, Poland.

Chobot AP, Deja G, Marcinkowski A, Myrda A, Minkina-Pedras M, Jarosz-Chobot P, Otto-Buczkowska E. Chobot AP, et al. Pediatr Endocrinol Diabetes Metab. 2007;13(2):75-8. Pediatr Endocrinol Diabetes Metab. 2007. PMID: 17880811

8

[The occurrence and analysis of chosen risk factors of DKA among children with new onset of DMT1].

Olak-Białoń B, Deja G, Jarosz-Chobot P, Buczkowska EO. Olak-Białoń B, et al. Pediatr Endocrinol Diabetes Metab. 2007;13(2):85-90. Pediatr Endocrinol Diabetes Metab. 2007. PMID: 17880813 Polish.

9

An analysis of the prevalence of thyroid autoantibodies: thyroid peroxidase antibodies (ATA) and thyroglobulin antibodies (ATG) in children with newly diagnosed diabetes mellitus type 1 during 2000-2004 in the Upper Silesia region, Poland.

Machnica L, Osior A, Jarosz-Chobot P, Deja G, Polanska J, Otto-Buczkowska E. Machnica L, et al. Acta Diabetol. 2008 Mar;45(1):37-40. doi: 10.1007/s00592-007-0017-4. Epub 2007 Oct 12. Acta Diabetol. 2008. PMID: 17932620

10

The rate of improvement in metabolic control in children with diabetes mellitus type 1 on insulin glargine depends on age.

Deja G, Jarosz-Chobot P, Polanska J. Deja G, et al. Exp Clin Endocrinol Diabetes. 2007 Nov;115(10):662-8. doi: 10.1055/s-2007-984444. Exp Clin Endocrinol Diabetes. 2007. PMID: 18058601

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

172 results

Search Page